Page last updated: 2024-10-27

gliclazide and Reperfusion Injury

gliclazide has been researched along with Reperfusion Injury in 2 studies

Gliclazide: An oral sulfonylurea hypoglycemic agent which stimulates insulin secretion.

Reperfusion Injury: Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA.

Research Excerpts

ExcerptRelevanceReference
"Gliclazide was administered intravenously into the right jugular vein for 12h simultaneously with the reperfusion."1.40Protective effect of treatment with low-dose gliclazide in a model of middle cerebral artery occlusion and reperfusion in rats. ( Li, H; Ma, M; Tan, F; Yu, Y, 2014)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tan, F1
Li, H1
Ma, M1
Yu, Y1
Bouskela, E1
Cyrino, FZ1
Conde, CM1
Garcia, AA1

Other Studies

2 other studies available for gliclazide and Reperfusion Injury

ArticleYear
Protective effect of treatment with low-dose gliclazide in a model of middle cerebral artery occlusion and reperfusion in rats.
    Brain research, 2014, Apr-29, Volume: 1560

    Topics: Animals; Apoptosis; Blood Glucose; Brain; Brain Ischemia; Disease Models, Animal; Gene Expression; G

2014
Microvascular permeability with sulfonylureas in normal and diabetic hamsters.
    Metabolism: clinical and experimental, 1997, Volume: 46, Issue:12 Suppl 1

    Topics: Animals; Calcium Channel Blockers; Calcium Channels; Capillary Permeability; Cricetinae; Dextrans; D

1997